NasdaqCM - Delayed Quote USD
Belite Bio, Inc (BLTE)
64.40
-2.67
(-3.98%)
At close: May 16 at 4:00:01 PM EDT
64.40
0.00
(0.00%)
After hours: May 16 at 4:05:08 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-29,234
-29,234
-29,837
-11,458
-7,474
Investing Cash Flow
-110,572
-110,572
-63
-394
-56
Financing Cash Flow
83,595
83,595
75,959
36,963
-583
End Cash Position
31,677
31,677
88,157
42,089
17,344
Income Tax Paid Supplemental Data
6
6
9
0
0
Interest Paid Supplemental Data
0
0
0
16
0
Capital Expenditure
-151
-151
-63
-394
-74
Issuance of Capital Stock
42,236
42,236
55,188
37,990
0
Issuance of Debt
--
--
--
0
0
Repayment of Debt
--
--
--
0
0
Free Cash Flow
-29,385
-29,385
-29,900
-11,852
-7,548
12/31/2021 - 4/29/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6696.TWO Lin BioScience, Inc.
143.00
+2.51%
7832.TWO Intelligene
13.40
-1.83%
CLSD Clearside Biomedical, Inc.
0.8789
+1.67%
RYTM Rhythm Pharmaceuticals, Inc.
59.93
-0.42%
ICU SeaStar Medical Holding Corporation
1.2400
0.00%
AKRO Akero Therapeutics, Inc.
38.87
-2.73%
CDXS Codexis, Inc.
2.4700
-1.59%
TNGX Tango Therapeutics, Inc.
1.5000
-1.32%
ZVRA Zevra Therapeutics, Inc.
8.66
+2.73%
ICCC ImmuCell Corporation
5.27
-0.57%